Lexicon Pharmaceuticals, Inc. (LXRX)
1.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
1.315
0.00 (0.00%)
Pre-Market: 20:00
Lexicon Pharmaceuticals EPS Diluted (Quarterly) : -0.0351 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novavax, Inc. | -1.246 |
| Viemed Healthcare, Inc. | 0.0867 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.77M |
| Revenue (Quarterly) | 14.18M |
| Total Expenses (Quarterly) | 26.95M |
| Enterprise Value | 425.05M |
| Gross Profit Margin (Quarterly) | 98.86% |
| Profit Margin (Quarterly) | -90.04% |
| Earnings Yield | -14.47% |
| Normalized Earnings Yield | -13.14 |